The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 28, 2023
Filed:
Aug. 13, 2021
Applicant:
Denali Therapeutics Inc., South San Francisco, CA (US);
Inventors:
Javier de Vicente Fidalgo, Foster City, CA (US);
Anthony A. Estrada, San Mateo, CA (US);
Jianwen A. Feng, San Mateo, CA (US);
Joseph P. Lyssikatos, South San Francisco, CA (US);
Zachary K. Sweeney, Redwood City, CA (US);
Assignee:
Denali Therapeutics Inc., South San Francisco, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); C07D 401/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 491/20 (2006.01); C07D 498/04 (2006.01); C07B 59/00 (2006.01); C07D 403/14 (2006.01); C07D 405/14 (2006.01); C07D 409/14 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); C07B 59/002 (2013.01); C07D 401/14 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 487/04 (2013.01); C07D 491/20 (2013.01); C07D 498/04 (2013.01); C07B 2200/05 (2013.01);
Abstract
The present disclosure relates generally to LRRK2 inhibitors, or a pharmaceutically acceptable salt, deuterated analog, prodrug, tautomer, stereoisomer, or mixture of stereoisomers thereof, and methods of making and using thereof.